These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20229133)

  • 1. St. John's Wort constituents modulate P-glycoprotein transport activity at the blood-brain barrier.
    Ott M; Huls M; Cornelius MG; Fricker G
    Pharm Res; 2010 May; 27(5):811-22. PubMed ID: 20229133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of P-glycoprotein function by St John's wort extract and its major constituents.
    Weber CC; Kressmann S; Fricker G; Müller WE
    Pharmacopsychiatry; 2004 Nov; 37(6):292-8. PubMed ID: 15551196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line.
    Tian R; Koyabu N; Morimoto S; Shoyama Y; Ohtani H; Sawada Y
    Drug Metab Dispos; 2005 Apr; 33(4):547-54. PubMed ID: 15640377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative characterization of direct P-glycoprotein inhibition by St John's wort constituents hypericin and hyperforin.
    Wang EJ; Barecki-Roach M; Johnson WW
    J Pharm Pharmacol; 2004 Jan; 56(1):123-8. PubMed ID: 14980009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saint John's wort: an in vitro analysis of P-glycoprotein induction due to extended exposure.
    Perloff MD; von Moltke LL; Störmer E; Shader RI; Greenblatt DJ
    Br J Pharmacol; 2001 Dec; 134(8):1601-8. PubMed ID: 11739235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. St. John's wort extract with a high hyperforin content does not induce P-glycoprotein activity at the human blood-brain barrier.
    El Biali M; Wölfl-Duchek M; Jackwerth M; Mairinger S; Weber M; Bamminger K; Poschner S; Rausch I; Schindler N; Lozano IH; Jäger W; Nics L; Tournier N; Hacker M; Zeitlinger M; Bauer M; Langer O
    Clin Transl Sci; 2024 May; 17(5):e13804. PubMed ID: 38700454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnane X receptor (PXR) regulates P-glycoprotein at the blood-brain barrier: functional similarities between pig and human PXR.
    Ott M; Fricker G; Bauer B
    J Pharmacol Exp Ther; 2009 Apr; 329(1):141-9. PubMed ID: 19147857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnane X receptor upregulates ABC-transporter Abcg2 and Abcb1 at the blood-brain barrier.
    Lemmen J; Tozakidis IE; Galla HJ
    Brain Res; 2013 Jan; 1491():1-13. PubMed ID: 23123212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prolonged protein kinase C-mediated, opioid-related antinociceptive effect of st John's Wort in mice.
    Galeotti N; Vivoli E; Bilia AR; Bergonzi MC; Bartolini A; Ghelardini C
    J Pain; 2010 Feb; 11(2):149-59. PubMed ID: 19945352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction and inhibition of cytochromes P450 by the St. John's wort constituent hyperforin in human hepatocyte cultures.
    Komoroski BJ; Zhang S; Cai H; Hutzler JM; Frye R; Tracy TS; Strom SC; Lehmann T; Ang CY; Cui YY; Venkataramanan R
    Drug Metab Dispos; 2004 May; 32(5):512-8. PubMed ID: 15100173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical risks of St John's Wort (Hypericum perforatum) co-administration.
    Soleymani S; Bahramsoltani R; Rahimi R; Abdollahi M
    Expert Opin Drug Metab Toxicol; 2017 Oct; 13(10):1047-1062. PubMed ID: 28885074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperforin content determines the magnitude of the St John's wort-cyclosporine drug interaction.
    Mai I; Bauer S; Perloff ES; Johne A; Uehleke B; Frank B; Budde K; Roots I
    Clin Pharmacol Ther; 2004 Oct; 76(4):330-40. PubMed ID: 15470332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypericum perforatum (St John's wort) beyond depression: A therapeutic perspective for pain conditions.
    Galeotti N
    J Ethnopharmacol; 2017 Mar; 200():136-146. PubMed ID: 28216196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro photochemical and phototoxicological characterization of major constituents in St. John's Wort (Hypericum perforatum) extracts.
    Onoue S; Seto Y; Ochi M; Inoue R; Ito H; Hatano T; Yamada S
    Phytochemistry; 2011 Oct; 72(14-15):1814-20. PubMed ID: 21782201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of NO-induced nociceptive hypersensitivity by St. John's wort and hypericin: NF-κB, CREB and STAT1 as molecular targets.
    Galeotti N; Ghelardini C
    Psychopharmacology (Berl); 2013 May; 227(1):149-63. PubMed ID: 23254377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of St. John's Wort standardized extract and hypericin on in vitro placental calcium transport.
    da Conceição AO; Takser L; Lafond J
    J Med Food; 2010 Aug; 13(4):934-42. PubMed ID: 20553141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro receptor screening of pure constituents of St. John's wort reveals novel interactions with a number of GPCRs.
    Butterweck V; Nahrstedt A; Evans J; Hufeisen S; Rauser L; Savage J; Popadak B; Ernsberger P; Roth BL
    Psychopharmacology (Berl); 2002 Jul; 162(2):193-202. PubMed ID: 12110997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. St. John's wort relieves pain in an animal model of migraine.
    Galeotti N; Ghelardini C
    Eur J Pain; 2013 Mar; 17(3):369-81. PubMed ID: 23152076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No relevant interaction with alprazolam, caffeine, tolbutamide, and digoxin by treatment with a low-hyperforin St John's wort extract.
    Arold G; Donath F; Maurer A; Diefenbach K; Bauer S; Henneicke-von Zepelin HH; Friede M; Roots I
    Planta Med; 2005 Apr; 71(4):331-7. PubMed ID: 15856409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperforin-containing extracts of St John's wort fail to alter gene transcription in brain areas involved in HPA axis control in a long-term treatment regimen in rats.
    Butterweck V; Winterhoff H; Herkenham M
    Neuropsychopharmacology; 2003 Dec; 28(12):2160-8. PubMed ID: 12865894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.